Present status, Standardization and safety issues with herbal drugs

  • Irfat Ara Regional Research Institute of Unani Medicine Hazratbal Srinagar-190006, Jammu and Kashmir, India.
  • Mudasir Maqbool Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal Srinagar-190006, Jammu and Kashmir, India https://orcid.org/0000-0002-9036-008X
  • Basharat Bukhari Regional Research Institute of Unani Medicine Hazratbal Srinagar-190006, Jammu and Kashmir, India.
  • Nighat Ara Regional Research Institute of Unani Medicine Hazratbal Srinagar-190006, Jammu and Kashmir, India.
  • Tawseef Ahmad Hajam Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal Srinagar-190006, Jammu and Kashmir, India. https://orcid.org/0000-0001-5717-3031
Keywords: Herbal drugs, adverse effects, Pharmacovigilance, clinical trials

Abstract

Traditional medicine is an important component of the health care system throughout world. Herbal medicine is the use of medicinal plants for prevention and treatment of various diseases. It ranges from traditional and popular medicines of every country to the use of standardized and analyzed herbal extracts. Although therapies involving these agents have shown promising potential with the efficacy of a good number of herbal products clearly established, many of them remain untested and their use are either poorly monitored or not even monitored at all. Herbal-derived remedies need a powerful and deep assessment of their pharmacological qualities and safety issues due to the large and growing use of natural-derived substances all over the world. Based on the current situation, worldwide research on herbal medicine safety is still not broad or deep enough. For next step, more attention should be paid to researches on the toxicity and the herb-drug interaction of commonly used herb medicines, which are the most necessary and urgent work. For clinical safety monitoring, spontaneous reporting system or active pharmacovigilance is effective in identifying therapeutically relevant safety issues. In this paper, an attempt has been made to summarize the information described in scientific research conducted about Present status, Standardization and safety concerns of herbal drugs.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Ai, J. (1999). Medicinal plants as a source of novel brain GABA A/benzodiazepine receptor ligands (Doctoral dissertation, Roskilde University, De-partment of Life sciences & Chemistry; Sct. Hans Hospital, Department of Biochemistry, Research Institute of Biological Psychiatry). Roskilde, Den-mark, P:167.

Buragohain, J. (2011). Ethnomedicinal plants used by the ethnic communities of Tinsukia district of Assam, India. Recent research in Science and Tech-nology, 3(9).

Mahwasane, S. T., Middleton, L., & Boaduo, N. (2013). An ethnobotanical survey of indigenous knowledge on medicinal plants used by the tradi-tional healers of the Lwamondo area, Limpopo province, South Africa. South African Journal of Botany, 88, 69-75.

Farnsworth, N. R., & Soejarto, D. D. (1985). Poten-tial consequence of plant extinction in the United States on the current and future availability of pre-scription drugs. Economic botany, 39(3), 231-240.

Gupta, L. M., & Raina, R. (1998). Side effects of some medicinal plants. Current Science, 75(9), 897-900.

Kala, C. P., Dhyani, P. P., & Sajwan, B. S. (2006). Developing the medicinal plants sector in northern India: challenges and opportunities. Journal of Eth-nobiology and Ethnomedicine, 2(1), 32.

DaSilva, E. J., Baydoun, E., & Badran, A. (2002). Biotechnology and the developing world. Electron-ic Journal of Biotechnology, 5(1), 1-2.

Kamboj VP (2000). Herbal Medicine. Current Sci-ence, 78, 35-9.

Fabricant, D. S. (2001). Approaches to drug discov-ery using higher plants. Environmental Health Per-spectives, 109(1), 69-75.

Mukherjee, P. K. (2002). Quality control of herbal drugs: an approach to evaluation of botanicals. Business Horizons.

Bodeker, G., & Ong, C. K. (2005). WHO global atlas of traditional, complementary and alternative med-icine (Vol. 1). World Health Organization.

Bandaranayake, W. M. (2006). Quality control, screening, toxicity, and regulation of herbal drugs. Modern Phytomedicine, 25-57. DOI: 10.1002/9783527609987.ch2

Pal, S. K. (2002). Complementary and alternative medicine: an overview. Current Science, 518-524.

Firenzuoli, F., Gori, L., Crupi, A., & Neri, D. (2004). Flavonoids: risks or therapeutic opportunities?. Recenti progressi in medicina, 95(7-8), 345-351.

Rates, S. M. K. (2001). Plants as source of drugs. Toxicon, 39(5), 603-613.

Harries, A., & Cullinan, T. (1994). Herbis et orbis: the dangers of traditional eye medicines. The lan-cet, 344(8937), 1588.

Zhang, X., & World Health Organization. (2002). Traditional medicine strategy 2002 2005.

Raynor, D. K., Dickinson, R., Knapp, P., Long, A. F., & Nicolson, D. J. (2011). Buyer beware? Does the information provided with herbal products availa-ble over the counter enable safe use?. BMC medi-cine, 9(1), 94. DOI: 10.1186/1741-7015-9-94

Vanherweghem, J. L., & Degaute, J. P. (1998). The policy of admission to the education in medicine and dentistry in the French-speaking community of Belgium. DOI: 10.1080/17843286.1998.11754133, PMID: 9562698

Cosyns, J. P., Jadoul, M., Squifflet, J. P., Wese, F. X., & de Strihou, C. V. Y. (1999). Urothelial lesions in Chinese-herb nephropathy. American journal of kidney diseases, 33(6), 1011-1017. DOI: 10.1016/S0272-6386(99)70136-8

Ernst, E. (2002). Toxic heavy metals and unde-clared drugs in Asian herbal medicines. Trends in pharmacological sciences, 23(3), 136-139. DOI: 10.1016/S0165-6147(00)01972-6

Kew, J., Morris, C., Aihie, A., Fysh, R., Jones, S., & Brooks, D. (1993). Arsenic and mercury intoxica-tion due to Indian ethnic remedies. BMJ: British Medical Journal, 306(6876), 506.

World Health Organization. (1998). Quality control methods for medicinal plant materials. World Health Organization.

Ernst, E. (2000). Herb-drug interactions: potential-ly important but woefully under-researched. Euro-pean Journal of Clinical Pharmacology, 56(8), 523-524. DOI: 10.1007/s002280000194

Zhang, Z. J., Tan, Q. R., Tong, Y., Wang, X. Y., Wang, H. H., Ho, L. M., ... & McAlonan, G. M. (2011). An epidemiological study of concomitant use of Chi-nese medicine and antipsychotics in schizophrenic patients: implication for herb-drug interaction. PloS one, 6(2). DOI: 10.1371/journal.pone.0017239 PMID: 21359185

Geneva, S. (2004). WHO Guide lines on Safety Mon-itoring of Herbal Medicines in Pharmacovigilance Systems.

Published
18-05-2020
How to Cite
Irfat Ara, Mudasir Maqbool, Basharat Bukhari, Nighat Ara, & Tawseef Ahmad Hajam. (2020). Present status, Standardization and safety issues with herbal drugs. International Journal of Research in Pharmaceutical Sciences and Technology, 1(3), 95-101. https://doi.org/10.33974/ijrpst.v1i3.169
Section
Review Article